C09CA06 • desartan cilexetil + hydrochlorothiazide • Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain
The combination of Desartanum cilexetil + Hydrochlorothiazidum is used for the treatment of essential hypertension in patients who do not respond adequately to monotherapy. It combines an angiotensin II receptor antagonist (desartanum cilexetil) with a thiazide diuretic (hydrochlorothiazidum) to lower blood pressure.
The medication is taken orally, usually once daily, and is effective in reducing the risk of cardiovascular complications such as stroke or myocardial infarction.
Side effects may include dizziness, headache, nausea, hypokalemia, or increased uric acid levels. It is important to monitor blood pressure and kidney function during treatment.
Consult your doctor to discuss the benefits and risks of treatment with Desartanum cilexetil + Hydrochlorothiazidum. Follow the prescribed dosage and adhere to all medical recommendations.
Substance: desartan cilexetil + hydrochlorothiazide
Date of last drug list: 01-07-2013
Commercial code: W56327002
Concentration: 16mg / 12.5mg
Pharmaceutical form: tablets
Quantity: 28
Product type: generic
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.